TerminatedPhase 3NCT04405271

TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study)

Studying Severe acute respiratory syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hospital Italiano de Buenos Aires
Principal Investigator
Waldo H Belloso, MD
Hospital Italiano de Buenos Aires
Intervention
Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet(drug)
Enrollment
1378 target
Eligibility
18 years · All sexes
Timeline
20202020

Study locations (1)

Collaborators

Sociedad Argentina de Infectología (SADI) (Argentine Society of Infectious Diseases)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04405271 on ClinicalTrials.gov

Other trials for Severe acute respiratory syndrome

Additional recruiting or active studies for the same condition.

See all trials for Severe acute respiratory syndrome

← Back to all trials